Cargando…
Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications
Diabetes is a widespread autoimmune disorder that affects nearly 10% of the adult population in the United States. In addition to the primary disease, there are numerous complications associated with inflammation including abnormalities of the heart, visual system, and peripheral nervous system. Mor...
Autores principales: | McLaughlin, Patricia J., Sassani, Joseph W., Zagon, Ian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198040/ https://www.ncbi.nlm.nih.gov/pubmed/32368758 http://dx.doi.org/10.33696/immunology.1.018 |
Ejemplares similares
-
Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes
por: McLaughlin, Patricia J., et al.
Publicado: (2019) -
Sex Differences in Diabetic Ocular Surface Complications and Dysregulation of the OGF-OGFr Pathway
por: Zagon, Ian S., et al.
Publicado: (2022) -
Elevated Opioid Growth Factor Alters the Limbus in Type 1 Diabetic Rats
por: McLaughlin, Patricia J., et al.
Publicado: (2023) -
Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats
por: Purushothaman, Indira, et al.
Publicado: (2021) -
Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis
por: Ludwig, Michael D, et al.
Publicado: (2016)